JP2007533672A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533672A5
JP2007533672A5 JP2007508756A JP2007508756A JP2007533672A5 JP 2007533672 A5 JP2007533672 A5 JP 2007533672A5 JP 2007508756 A JP2007508756 A JP 2007508756A JP 2007508756 A JP2007508756 A JP 2007508756A JP 2007533672 A5 JP2007533672 A5 JP 2007533672A5
Authority
JP
Japan
Prior art keywords
formula
compound
aminopyridin
imidazol
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007508756A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533672A (ja
JP4939401B2 (ja
Filing date
Publication date
Priority claimed from DE102004020186A external-priority patent/DE102004020186A1/de
Application filed filed Critical
Publication of JP2007533672A publication Critical patent/JP2007533672A/ja
Publication of JP2007533672A5 publication Critical patent/JP2007533672A5/ja
Application granted granted Critical
Publication of JP4939401B2 publication Critical patent/JP4939401B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007508756A 2004-04-22 2005-04-07 TAFIa阻害剤として用いるイミダゾール誘導体 Expired - Fee Related JP4939401B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004020186A DE102004020186A1 (de) 2004-04-22 2004-04-22 Heterocyclylessigsäuren als Inhibitoren von TAFla
DE102004020186.2 2004-04-22
PCT/EP2005/003630 WO2005105781A1 (de) 2004-04-22 2005-04-07 Imidazol-derivate als tafia-inhibitoren

Publications (3)

Publication Number Publication Date
JP2007533672A JP2007533672A (ja) 2007-11-22
JP2007533672A5 true JP2007533672A5 (cg-RX-API-DMAC10.html) 2008-05-08
JP4939401B2 JP4939401B2 (ja) 2012-05-23

Family

ID=34964308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007508756A Expired - Fee Related JP4939401B2 (ja) 2004-04-22 2005-04-07 TAFIa阻害剤として用いるイミダゾール誘導体

Country Status (34)

Country Link
EP (2) EP1864979B1 (cg-RX-API-DMAC10.html)
JP (1) JP4939401B2 (cg-RX-API-DMAC10.html)
KR (1) KR101162047B1 (cg-RX-API-DMAC10.html)
CN (1) CN100572376C (cg-RX-API-DMAC10.html)
AR (1) AR053302A1 (cg-RX-API-DMAC10.html)
AT (2) ATE523505T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005238144B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0510159A (cg-RX-API-DMAC10.html)
CA (1) CA2563401C (cg-RX-API-DMAC10.html)
CR (1) CR8650A (cg-RX-API-DMAC10.html)
CY (1) CY1108087T1 (cg-RX-API-DMAC10.html)
DE (2) DE102004020186A1 (cg-RX-API-DMAC10.html)
DK (1) DK1740569T3 (cg-RX-API-DMAC10.html)
EC (1) ECSP066941A (cg-RX-API-DMAC10.html)
ES (1) ES2299026T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20080099T3 (cg-RX-API-DMAC10.html)
IL (1) IL178672A (cg-RX-API-DMAC10.html)
MA (1) MA28543B1 (cg-RX-API-DMAC10.html)
MY (1) MY140903A (cg-RX-API-DMAC10.html)
NI (1) NI200600217A (cg-RX-API-DMAC10.html)
NO (1) NO20065320L (cg-RX-API-DMAC10.html)
NZ (1) NZ550757A (cg-RX-API-DMAC10.html)
PE (1) PE20060172A1 (cg-RX-API-DMAC10.html)
PL (1) PL1740569T3 (cg-RX-API-DMAC10.html)
PT (1) PT1740569E (cg-RX-API-DMAC10.html)
RS (1) RS50553B (cg-RX-API-DMAC10.html)
RU (1) RU2375356C2 (cg-RX-API-DMAC10.html)
SI (1) SI1740569T1 (cg-RX-API-DMAC10.html)
TN (1) TNSN06341A1 (cg-RX-API-DMAC10.html)
TW (1) TWI359016B (cg-RX-API-DMAC10.html)
UA (1) UA87306C2 (cg-RX-API-DMAC10.html)
UY (1) UY28868A1 (cg-RX-API-DMAC10.html)
WO (1) WO2005105781A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200607668B (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ577312A (en) 2006-12-06 2012-02-24 Sanofi Aventis Urea and sulfamide derivatives as tafia inhibitors
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
WO2008100459A1 (en) * 2007-02-13 2008-08-21 Schering Corporation Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
AU2008279447A1 (en) * 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
EP2262783A2 (en) * 2008-02-21 2010-12-22 Sanofi-Aventis Covalently binding imaging probes
MX2010012793A (es) * 2008-06-06 2010-12-14 Sanofi Aventis Derivados de urea macrociclicos y de sulfamida como inhibidores de tafia.
AU2009310841A1 (en) 2008-10-29 2010-05-06 Taisho Pharmaceutical Co., Ltd. Compounds having TAFIa inhibitory activity
US8865906B2 (en) * 2009-05-15 2014-10-21 Sanofi Process for the preparation of a compound useful as an inhibitor of TAFIa
FR2947266B1 (fr) * 2009-06-26 2011-06-17 Servier Lab Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
KR20130006620A (ko) 2010-03-18 2013-01-17 다이이찌 산쿄 가부시키가이샤 시클로프로판카르복실산 유도체
SG10201502026XA (en) 2010-03-18 2015-05-28 Daiichi Sankyo Co Ltd Cycloalkyl-substituted imidazole derivative
WO2012062730A1 (en) 2010-11-11 2012-05-18 Sanofi Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives
EP2782576B1 (en) * 2011-11-25 2016-05-18 Sanofi Sodium salt of (r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
EP2782575B1 (en) 2011-11-25 2016-04-20 Sanofi Crystalline salts of r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
US9156815B2 (en) 2011-11-25 2015-10-13 Sanofi Salt of (R)-3-(6-amino-pyridin-3-yl)-2-(1-Cyclohexyl-1H-imidazol-4-yl) ethyl propionate
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
RU2015156612A (ru) * 2013-06-10 2017-07-17 Санофи Макроциклические производные мочевины в качестве ингибиторов tafia, их получение и их применение в качестве фармацевтических средств
US20190117624A1 (en) 2016-03-29 2019-04-25 Daiichi Sankyo Company, Limited Therapeutic agent for inflammatory bowel diseases
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012338A3 (cs) * 1998-12-24 2001-12-12 Fujisawa Pharmaceutical Co., Ltd. Imidazolové sloučeniny
WO2003013526A1 (en) 2001-08-08 2003-02-20 Merck & Co. Inc. Anticoagulant compounds
CA2472239A1 (en) 2002-01-22 2003-07-31 Pfizer Inc. 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases

Similar Documents

Publication Publication Date Title
JP2004534825A5 (cg-RX-API-DMAC10.html)
KR102143257B1 (ko) 인자 XIa 억제제의 결정질 형태
WO2011118672A1 (ja) 血漿カリクレイン阻害剤
JP2021523887A (ja) XIIa因子インヒビター
JP2004532250A (ja) 線維性疾患又は他の適応症の治療方法
JP2015164972A5 (cg-RX-API-DMAC10.html)
JP2005526696A5 (cg-RX-API-DMAC10.html)
JP2004533464A (ja) ヘテロアリールスルホニル側鎖を有するアントラニル酸アミド、その製造方法、その医薬または診断助剤としての使用、およびこの化合物を含有する医薬製剤
JP2007527919A5 (cg-RX-API-DMAC10.html)
JP2008534552A5 (cg-RX-API-DMAC10.html)
RU2012144332A (ru) Циклоалкил-замещенное производное имидазола
JP2013536864A5 (cg-RX-API-DMAC10.html)
WO2002066447A1 (en) 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors
TW202237112A (zh) 用於治療貧血的化合物及組成物
CN100572376C (zh) 用作tafia抑制剂的咪唑衍生物
JP2009543844A (ja) 直接トロンビン阻害剤の新しい小児適応症
JP2005528459A5 (cg-RX-API-DMAC10.html)
JP2868283B2 (ja) 新規アリールスルホンアミド、それを含む医薬組成物及びその製造法
JP2014221839A (ja) Mmp−2及び/又はmmp−9阻害剤
JP2018522024A5 (cg-RX-API-DMAC10.html)
JP2005533064A (ja) 2,5−ジ置換3−メルカプトペンタン酸
CN113056263A (zh) 治疗化合物和组合物
JPWO2004000813A1 (ja) フェノキシピリジン誘導体又はその塩
JP4177663B2 (ja) 新規な結晶形のXa因子阻害剤
JP2008519826A5 (cg-RX-API-DMAC10.html)